JPRN-UMIN000006764已完成未知
Prediction of response of EGFR tyrosine kinase inhibtors by plasma DNA - Prediction of response of EGFR-TKI by plasma DNA
Osaka Medical Center for Cancer and Cardiovascular Diseases0 个研究点目标入组 38 人开始时间: 2011年11月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 38
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •No exclusion
研究者
相似试验
招募中
不适用
A study of the resistance mechanism of EGFR-TKI in EGFR gene mutation positive non-small cell lung cancerJPRN-UMIN000031013Kyoto prefectural University of Medicine35
尚未招募
Unknown
A Clinical Study on Drug Resistance in CML(Chronic Myeloid Leukemia)CTRI/2024/08/072505Indian Council Of Medical Research
已完成
不适用
Clinical study of a combined use of EGFR-TKI and autologous lymphocyte-activated killer cells (LAK) therapy for advanced non-small cell lung cancer.non-small cell lung cancerJPRN-UMIN000001966Juntendo University, School of Medicine10
进行中（未招募）
不适用
Prediction of response to kinase inhibitors based on protein phosphorylation profiles in tumor tissue from advanced renal cell cancer patientsEUCTR2011-006009-85-NLVU University medical center225
已完成
不适用
Prediction of response to kinase inhibitors based on protein phosphorylation profiles in tumor tissue from advanced renal cell cancer patientskidney cancerRenal cell cancer10038364NL-OMON37502Vrije Universiteit Medisch Centrum225